Z. Chen

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

Marjolein de Bruin‐Weller, Diamant Thaçi, Catherine Smith et al. · British Journal of Dermatology · 2017 · 475 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

Conjunctivitis in dupilumab clinical trials

Bolanle Akinlade, Emma Guttman‐Yassky, Marjolein de Bruin‐Weller et al. · British Journal of Dermatology · 2019 · 422 citations · Full text

Medicine, Dermatology, Immunology +11

Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis

Gil Yosipovitch, Matthew Reaney, Vera Mastey et al. · British Journal of Dermatology · 2019 · 378 citations · Full text

Medicine, Dermatology, Immunology +16

Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase <scp>II</scp> a open‐label trial and subsequent phase <scp>III</scp> open‐label extension

Michael J. Cork, Diamant Thaçi, Lawrence F. Eichenfield et al. · British Journal of Dermatology · 2019 · 145 citations · Full text

Medicine, Dermatology, Pharmacology +15

Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase <scp>III</scp> trials

Jonathan I. Silverberg, Eric L. Simpson, Marius Ardeleanu et al. · British Journal of Dermatology · 2019 · 60 citations · Full text

Life Sciences, Dermatology, Pharmacotherapy +15